Olink®Part of Thermo Fisher Scientific
Capture true biological insights with proven specificity. At any scale.
A unique combination of specificity and scalability enables high-throughput, multiplex protein biomarker analysis.
Next-generation high-throughput proteomics empowers genetically-informed assessment of protein causality and the confident identification of novel drug targets.
Join the growing global community and consortia of Olink users to empower your biomarker discovery.
Over 1,800 and growing rapidly – covering all major disease areas
Help shape the future of health research with Olink’s cutting-edge technology
Filters
Allergy, 2023Mechanisms of gut epithelial barrier impairment caused by food emulsifiers polysorbate 20 and polysorbate 80
Ogulur I., Yazici D., Pat Y. et al.
Olink Target 96
International Immunopharmacology, 2023Cytokine patterns in the blister fluid and plasma of patients with fracture blisters
Li Y., Long Y., Chen X. et al.
Journal of Allergy and Clinical Immunology, 2023Integrated proteomics and genomics analysis of paradoxical eczema in psoriasis patients treated with biologics
Al-Janabi A., Martin P., Khan A. et al.
Cytokine, 2023Lower levels of Th1 and Th2 cytokines in cerebrospinal fluid (CSF) at the time of initial CSF shunt placement in children are associated with subsequent shunt revision surgeries
Simon T., Sedano S., Rosenberg-Hasson Y. et al.
European Journal of Immunology, 2023Proteomics reveals a global phenotypic shift of NK cells in HCV patients treated with direct‐acting antivirals
Bi W., Kraft A., Engelskircher S. et al.
Clinical and Molecular Allergy, 2023Systemic inflammatory proteins in offspring following maternal probiotic supplementation for atopic dermatitis prevention
Zakiudin D., Rø A., Videm V. et al.
JAMA Network Open, 2023Biomarkers Associated With Severe COVID-19 Among Populations With High Cardiometabolic Risk
Sood T., Perrot N., Chong M. et al.
Hematological Oncology, 2023Safety and efficacy of parsaclisib in combination with obinutuzumab and bendamustine in patients with relapsed or refractory follicular lymphoma (CITADEL‐102): A phase 1 study
Hamadani M., Coleman M., Boccia R. et al.
eBioMedicine, 2023Plasma proteomic profiling identifies CD33 as a marker of HIV control in natural infection and after therapeutic vaccination
Duran-Castells C., Prats A., Oriol-Tordera B. et al.
Journal of Circulating Biomarkers, 2023Protein Detection Using the Multiplexed Proximity Extension Assay (PEA) from Plasma and Vaginal Fluid Applied to the Indicating FTA Elute Micro Card™
Berggrund M., Ekman D., Gustavsson I. et al.
Translational Research, 2023Plasma protein signatures reflect systemic immunity and allograft function in kidney transplantation
Buscher K., Rixen R., Schütz P. et al.
Pulmonary Circulation, 2023Plasma TRAIL and ANXA1 in diagnosis and prognostication of pulmonary arterial hypertension
Arvidsson M., Ahmed A., Säleby J. et al.
Frontiers in Immunology, 2023Multi-omic analysis of the tumor microenvironment shows clinical correlations in Ph1 study of atezolizumab +/- SoC in MM
Wong S., Hamidi H., Costa L. et al.
Journal of the American Heart Association, 2023Novel Biomarkers of Necrotizing Enterocolitis in Neonates Undergoing Congenital Heart Disease Surgery: A Pilot Cohort Study
Ali E., Syed A., Khailova L. et al.
Olink Explore 3072/384
Diabetes, Obesity and Metabolism, 2023Hypoglycaemia induces a sustained pro‐inflammatory response in people with type 1 diabetes and healthy controls
Verhulst C., van Heck J., Fabricius T. et al.
European Journal of Neurology, 2023Paraneoplastic or not? Sirtuin 2 in anti‐N‐methyl‐d‐aspartate receptor encephalitis
Stevens‐Jones O., Mojzisova H., Elisak M. et al.
Cardiovascular Research, 2023A machine learning based approach to identify carotid subclinical atherosclerosis endotypes
Chen Q., Bergman O., Ziegler L. et al.
Journal of Dermatological Science, 2023Multi-omics approach identifies PI3 as a biomarker for disease severity and hyper-keratinization in psoriasis
Deng J., Leijten E., Zhu Y. et al.
Neurological Research and Practice, 2023Novel inflammatory biomarkers associated with stroke severity: results from a cross-sectional stroke cohort study
Braadt L., Naumann M., Freuer D. et al.
Science Translational Medicine, 2023Targeting the Siglec–sialic acid axis promotes antitumor immune responses in preclinical models of glioblastoma
Schmassmann P., Roux J., Buck A. et al.
1889 publications
Items per page
481-500 of 1889 publications